Integrated Diagnostics Holdings plc (LON:IDHC – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 0.62 and traded as low as GBX 0.55. Integrated Diagnostics shares last traded at GBX 0.56, with a volume of 96,470 shares trading hands.
Integrated Diagnostics Stock Performance
The stock has a market capitalization of £3.26 million, a PE ratio of 0.00, a price-to-earnings-growth ratio of 7.65 and a beta of 0.38. The stock has a fifty day moving average of GBX 0.59 and a 200-day moving average of GBX 0.62. The company has a quick ratio of 0.75, a current ratio of 1.53 and a debt-to-equity ratio of 43.40.
About Integrated Diagnostics
IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.
Read More
- Five stocks we like better than Integrated Diagnostics
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for Integrated Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
